Connect with us
Financial Press
london-markets:-astrazeneca-rallies-while-glaxosmithkline-eases-as-ftse-100-slips
london-markets:-astrazeneca-rallies-while-glaxosmithkline-eases-as-ftse-100-slips

Breaking

London Markets: AstraZeneca rallies while GlaxoSmithKline eases as FTSE 100 slips

London Markets


Prince William, Duke of Cambridge, wears a face mask as a precautionary measure against spreading COVID-19 and talks to a patient participating in a COVID-19 vaccine trial at Oxford Vaccine Group’s facility in Oxford, England, on June 24, 2020.


steve parsons/Agence France-Presse/Getty Images

AstraZeneca and GlaxoSmithKline headed in opposite directions on Monday, as the two heavyweight pharmaceuticals were in the spotlight over vaccine news.

AstraZeneca
AZN,
+0.53%

AZN,
+0.01%

gained 1.6% — off its best levels of the day — as the eagerly awaited study of the University of Oxford vaccine was published.

By one measure, the study said, neutralizing antibody responses were found in everyone who received the vaccine, as it also found the vaccine was safe.

Further clinical studies, including in older adults, should be done with this vaccine, the article said.

GlaxoSmithKline
GSK,
-0.96%

GSK,
+0.21%
,
meanwhile, weakened 0.2% as the U.K. drugmaker reached a deal worth up to £866 million to take a nearly 10% stake in Germany’s CureVac and fund up to five vaccines.

An AIM-listed stock, Synairgen
SNG,
+360.27%
,
jumped 370% after announcing positive results from a trial in hospitalized COVID-19 patients. The odds of developing severe disease during the treatment period were significantly reduced by 79% for patients receiving its SNG001 compared with patients who received placebo, the company said.

The broader FTSE 100
UKX,
-0.54%

slipped 0.5%, the worst-performing of the major European indexes. Analysts at JPMorgan Cazenove noted the U.K. is by far the worst performing index in dollar terms this year — and in each of the past five years — though they now upgraded the U.K. to neutral from underweight.

The analysts say the worst of the fallout from the reduction in dividends is now over.

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Breaking

My wife and I are both 57 and looking to retire at 62.  We will get approximately $1,700 a month each from Social Security. ...

Breaking

The Conversation Published: Sept. 26, 2020 at 5:14 p.m. ET What do communities like “People of Praise” believe? President Donald Trump announces his Supreme...

Breaking

NewsWatch Published: Sept. 26, 2020 at 5:00 p.m. ET MARKETWATCH FRONT PAGE Federal tax relief for new homeowners would help millennials and support prices,...

Breaking

Economic Preview Published: Sept. 26, 2020 at 4:54 p.m. ET Despite improvement, the U.S. unemployment rate remains historically high and financial woes are just...